Randomized, Crossover Safety and Pharmacokinetics Study of PT010

NCT02197975 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: PT010 Dose 1
DRUG: PT010 Dose 2
DRUG: Placebo MDI

Sponsor

Pearl Therapeutics, Inc.